Enhancement of Quercetin Oral Bioavailability by Self-Nanoemulsifying Drug Delivery System and their Quantification Through Ultra High Performance Liquid Chromatography and Mass Spectrometry in Cerebral Ischemia

Niyaz Ahmad; Rizwan Ahmad; Atta Abbas Naqvi; Md Aftab Alam; Rehan Abdur Rub; Farhan Jalees Ahmad

doi:10.1055/s-0043-109564

Drug Research, Inhaltsverzeichnis

Drug Res (Stuttg) 2017; 67(10): 564-575
DOI: 10.1055/s-0043-109564

Original Article

Enhancement of Quercetin Oral Bioavailability by Self-Nanoemulsifying Drug Delivery System and their Quantification Through Ultra High Performance Liquid Chromatography and Mass Spectrometry in Cerebral Ischemia

Niyaz Ahmad

¹Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University (Formerly University of Dammam), Dammam, Kingdom of Saudi Arabia

,

Rizwan Ahmad

²Department of Natural Products and Alternative Medicine, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University (Formerly University of Dammam), Dammam, Kingdom of Saudi Arabia

,

Atta Abbas Naqvi

³Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University (Formerly University of Dammam), Dammam, Kingdom of Saudi Arabia

,

Md Aftab Alam

⁴Department of Pharmaceutics, School of Medical and Allied Sciences, Galgotias University, Gautam Budh Nagar, Greater Noida, India

,

Rehan Abdur Rub

⁵Nanomedicine Lab, Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, India

,

Farhan Jalees Ahmad

⁵Nanomedicine Lab, Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, India

› Institutsangaben

Abstract

Background Quercetin (Qur) and its major in vivo bioactive metabolites i. e., 3′-O-methyl quercetin, 4′-O-methyl quercetin and quercetin 7-O-β-D-glucuronide, may be used to treat cerebral ischemia however the poor aqueous solubility and less intestinal absorption of Qur results low bioavailability.

Purpose To improve Qur bioavailability through preparation of nanoformulation and to develop and validate a sensitive quantification method for Qur detection in brain homogenate.

Methods Qur-containing self-nanoemulsifying drug delivery system (Qur-SNEDDS) was developed to form oil-in-water nanoemulsions in situ. Ultra-high performance liquid chromatography electrospray ionization-synapt mass spectrometric method (UHPLC/ESI-QTOF-MS/MS) was developed and validated for quantification whereas for optimal recovery of analyte, a liquid-liquid extraction method (LLE) was used.

Results A droplet size of 94.63±3.17 nm and zeta potential of −17.91±1.02 mV for nanoemuslion, elution time for Qur and internal standard (IS) Rutin as 1.21 and 1.50 min alongwith a transition at m/z 301.04/151.03 and 609.21/299.21, were observed respectively. Similarly, linear dynamic range (1.00 ng/mL–2 000.0 ng/mL), intra and inter-assay i. e., %CV of 0.26–2.04, lower limit of detection (LOD) 0.08 ng/mL as well as lower limit of quantitation (LOQ) as 0.131 ng/mL were also observed.

Conclusion The developed method have advantage over previous all methods i. e., less time consuming (<3.0), low consumption of solvents (flow rate 0.20 mL/min.) via small size column, more accuracy and specificity as well as use of acetonitrile as compared to hazardous solvents. This certainly adds advantages for green chromatography technique and supports application of current developed method for quantification and evaluation of Qur-SNEDDS.

Volltext

Referenzen

References
1 Ahmad A, Khan MM, Hoda MN. et al. Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochem Res 2011; 36: 1360-1371
2 Kovalenko TM, Osadchenko IO, Tsupykov OM. et al. Neuroprotective effect of quercetin during experimental brain ischemia. Fiziol Zh 2006; 52: 21-27
3 Rivera F, Costa G, Abin A. et al. Reduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in rats. Neurotox Res 2008; 13: 105-114
4 Zhang ZJ, Cheang LC, Wang MW. et al. Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med 2011; 27: 195-203
5 Anwer MK, Al-Mansoor MA, Jamil S. et al. Development and evaluation of PLGA polymer based nanoparticles of quercetin. Int J Biol Macromol 2016; 92: 213-219
6 Tran TH, Guo Y, Song D. et al. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. J Pharm Sci 2014; 103: 840-852
7 Ebrahimi P, Salmanpour S. Topical Quercetin Nanoemulsions: Optimization of preparation using chemometric approaches. Pharmaceutical Chemistry Journal 2014; 48: 402-407
8 Karadag A, Yang X, Ozcelik B. et al. Optimization of preparation conditions for quercetin nanoemulsions using response surface methodology. J Agric Food Chem 2013; 61: 2130-2239
9 Nathiya S, Durga M, Devasena T. Quercetin, Encapsulated quercetin and its application- A review. International Journal of Pharmacy and Pharmaceutical Sciences 2014; 6: 20-26
10 Kakran M, Sahoo NG, Li L. Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids Surf B Biointerfaces 2011; 88: 121-171
11 Gao Y, Wang Y, Ma Y. et al. Formulation optimization and in situ absorption in rat intestinal tract of quercetin loaded microemulsion. Colloids Surf B Biointerfaces 2009; 71: 306-314
12 Gao L, Liu G, Wang X. et al. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int J Pharm 2011; 404: 231-237
13 Li H, Zhao X, Ma Y. et al. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009; 133: 238-244
14 Beg S, Jena SS, Patra ChN. et al. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloids Surf B Biointerfaces 2013; 101: 414-423
15 Wang L, Dong J, Chen J. et al. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 2009; 330: 443-448
16 Date AA, Nagarsenker MS. Nagarsenker, Design and evaluation of selfnanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 2007; 329: 166-172
17 Date AA, Desai N, Dixit R. et al. Selfnanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine (Lond) 2010; 5: 1595-1616
18 Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res 1995; 12: 1561-1572
19 Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: Precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci 2009; 98: 3582-3595
20 Zhao G, Duan J, Xie Y. et al. Effect of solid dispersion and self-emulsifying formulation on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L. Drug Dev Ind Pharm 2013; 39: 1037-1045
21 Jain S, Jain AK, Pohekar M. et al. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: Implications on drug induced cardiotoxicity and nephrotoxicity. Free Radic Biol Med. 2013; 65: 117-230
22 Jang GH, Kim HW, Lee MK et al. Characterization and Quantification of Flavonoid Glycosides in the Prunus Genus by UPLC-DAD-QTOF/MS. 2016; http://dx.doi.org/10.1016/j.sjbs.2016.08.001
23 Farag MA, Mohsen M, Heinke R. et al. Metabolomic fingerprints of 21 date palm fruit varieties from Egypt using UPLC/PDA/ESI–qTOF-MS and GC–MS analyzed by chemometrics. Food Research International 2014; 64: 218-226
24 Kumari S, Elancheran R, Kotoky J. et al. Rapid screening and identification of phenolic antioxidants in Hydrocotyle sibthorpioides Lam. by UPLC–ESI-MS/MS. Food Chem 2016; 203: 521-529
25 Yao X, Zhou GS, Tang YP. et al. Quercetin-3-O-β-D-glucopyranosyl-(4 1)-α-L-rhamnoside metabolites in the rat using UPLC-Q-TOF/MS. Chin J Nat Med 2014; 12: 705-711
26 Kumar S, Lather V, Pandita D. Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma. Food Chem 2016; 197 Pt A 959-964
27 Zhang WM, Li RF, Sun M. et al. UPLC–MS/MS method for determination of avicularin in rat plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 965: 107-111
28 FDA, Guidance for Industry Bioanalytical Method Validation, 2001. Avalable from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf Accessed in June (2001)
29 Ahmad N, Warsi MH, Iqbal Z. et al. Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles. Drug Test Anal 2014; 6: 257-267
30 Ahmad N, Ahmad I, Umar S. et al. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-TOF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model. Drug Deliv 2016; 23: 2095-2114
31 Mustafa G, Ahmad N, Baboota S. et al. UHPLC/ESI-Q-TOF-MS method for the measurement of dopamine in rodent striatal tissue: A comparative effects of intranasal administration of ropinirole solution over nanoemulsion. Drug Test Anal 5: 702-709
32 Faiyazuddin M, Ahmad N, Khar RK. et al. Stabilized terbutaline submicron drug aerosol for deep lungs deposition: Drug assay, pulmonokinetics and biodistribution by UHPLC/ESI-q-TOF-MS method. Int J Pharm 2012; 434: 59-69
33 Wilson ID, Nicholson JK, Castro-Perez J. et al. High resolution “ultra performance” liquid chromatography coupled to q-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 2005; 4: 591-598
34 Balakrishnan P, Lee BJ, Oh DH. et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009; 72: 539-545
35 Prasad D, Chauhan H, Atef E. Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium. J Pharm Pharmacol 2013; 65: 1134-1144
36 Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization. Int J Pharm 2010; 391: 203-211
37 Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58: 173-182
38 Rhee YS, Choi JG, Park ES. et al. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm 2001; 228: 161-170
39 Puranajoti P, Kasina R, Tenjarla S. Microbiological and HPLC analysis of miconazole in skin, serum and phase-solubility studies. J Clin Pharm Ther 1999; 24: 445-450
40 Hadgraft J. Modulation of the barrier function of the skin, Skin Pharmacol. Appl Skin Physiol 2001; 14: 72-81
41 Ahmad N, Ahmad R, Alam MA. et al. Quantification and Evaluation of Thymoquinone loaded Mucoadhesive Nanoemulsion for treatment of Cerebral Ischemia. Int J Biol Macromol 2016; 88: 320-332
42 Parmar N, Singla N, Amin S. et al. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf B Biointerfaces 2011; 86: 327-338
43 Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (TaxolR). J Control Release 2002; 80: 129-144
44 Spencer JP, Kuhnle GG, Williams RJ. et al. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 2003; 372: 173-181
45 Bouktaib M, Atmani A, Rolando C. Regio- and stereoselective synthesis of the major metabolite of quercetin, quercetin-3-O-β-D-glucuronide. Tetrahedron Letters 2002; 43: 6263-6266
46 Cialdella-Kam L, Nieman DC, Sha W. et al. Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults. Br J Nutr. 2013; 109: 1923-1933